Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.58
+2.3%
$5.02
$3.42
$7.20
$255.21M1.751.58 million shs708,073 shs
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$24.12
+1.2%
$23.29
$6.20
$29.27
$266.67M-0.11132,679 shs40,233 shs
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.34
+2.4%
$0.34
$0.30
$0.80
$63.64M0.8911,194 shs13,110 shs
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$8.15
+0.4%
$5.23
$1.73
$10.43
$253.07M3.351.08 million shs556,044 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%+10.24%-15.43%+14.09%-6.63%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
0.00%+9.24%+2.68%+0.58%+2,411,999,900.00%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00%+4.09%-13.23%+6.53%-36.87%
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
0.00%+3.49%+70.40%+291.59%+185.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.1847 of 5 stars
0.01.00.00.01.60.80.6
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3.4488 of 5 stars
3.60.00.00.03.04.20.6
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.0874 of 5 stars
0.02.00.00.00.01.70.0
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
2.3972 of 5 stars
3.52.00.00.02.42.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3.13
Buy$46.2991.90% Upside
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00
N/AN/AN/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
3.00
Buy$26.60226.58% Upside

Current Analyst Ratings Breakdown

Latest PYRGF, SGMT, PVLA, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $27.00
5/16/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$53.00 ➝ $52.00
4/30/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$38.00 ➝ $38.00
4/9/2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$50.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$246.72M1.04$0.62 per share7.43$7.78 per share0.59
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$42.81M6.23N/AN/A$5.58 per share4.32
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$9.14M6.96N/AN/A($0.01) per share-34.09
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$2M124.90N/AN/A$5.08 per share1.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$1.63M$0.1141.5910.40N/A1.32%0.13%0.10%8/6/2025 (Estimated)
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
-$17.43M-$12.10N/AN/AN/AN/A-60.29%-43.30%8/13/2025 (Estimated)
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-$21.12M-$0.02N/AN/A-115.14%N/A-60.81%N/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
-$45.57M-$1.76N/AN/AN/AN/A-35.21%-34.09%8/13/2025 (Estimated)

Latest PYRGF, SGMT, PVLA, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/18/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11$0.07-$0.04-$0.24$88.85 million$63.34 million
5/15/2025Q1 2025
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
-$3.40-$0.74+$2.66-$0.74N/AN/A
5/8/2025Q1 2025
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
-$0.79-$0.56+$0.23-$0.56N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
N/AN/AN/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/AN/AN/AN/AN/A
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.13
4.31
2.16
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
N/A
8.84
8.84
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/A
0.60
0.50
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
N/A
20.34
20.34

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
40.11%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.03%
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
87.86%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
20.50%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
47.68%
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
14.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13056.21 million56.21 millionOptionable
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
N/A11.06 million8.79 millionN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
90186.69 million96.34 millionNo Data
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
830.67 million26.17 millionOptionable

Recent News About These Companies

SGMT Sagimet Biosciences Inc. - Seeking Alpha
Sagimet Biosciences Inc. (SGMT) - Yahoo Finance
Sagimet Biosciences Inc.
Sagimet Biosciences Analyst Ratings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.58 +0.11 (+2.35%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$4.57 -0.01 (-0.22%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Palvella Therapeutics stock logo

Palvella Therapeutics NASDAQ:PVLA

$24.12 +0.29 (+1.22%)
As of 07/3/2025 01:00 PM Eastern

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

PyroGenesis Canada stock logo

PyroGenesis Canada NASDAQ:PYRGF

$0.34 +0.01 (+2.37%)
As of 07/3/2025 12:24 PM Eastern

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. The company offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. It provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montreal, Canada.

Sagimet Biosciences stock logo

Sagimet Biosciences NASDAQ:SGMT

$8.14 +0.04 (+0.43%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$8.14 0.00 (0.00%)
As of 07/3/2025 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, a once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other oncology programs. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.